News Release(2016)

December 15, 2016

Announcement of an Agreement for the Co-Promotion of an immunosuppressant Imuran®Tablets 50 mg

October 28, 2016

Japanese NDA for an ulcerative colitis treatment agent (Development code: AJG511) was filed.

August 9, 2016

Kissei and JCR to Initiate a Phase III Clinical Trial of a Long-Acting Erythropoiesis-Stimulating Agent (Development Code: JR-131)

June 16, 2016

Announcement of the Launch of Glufast ®OD Tab. (Orally Disintegrating Tablets)

May 27, 2016

Announcement of Additional Clinical Trial of "KPS-0373 (Development Code)" for the Treatment of Spinocerebellar Ataxia

March 30, 2016

Kissei and Kyorin signed an Agreement for Co-Development and Co-Marketing of KRP-114V

January 15, 2016

Announcement of the Launch of Urief® OD Tab. (Orally Disintegrating Tablets) for the Treatment of Dysuria Associated with Benign Prostatic Hyperplasia in Japan